Kamil Faridi, MD, MSc
Assistant ProfessorCards
About
Research
Publications
2025
Long-Term Outcomes Following Left Atrial Appendage Occlusion in Medicare Beneficiaries: Outcomes From the National Cardiovascular Data Registry.
Higgins A, Zimmerman S, Wang Y, Friedman D, Faridi K, Price M, Reddy V, Holmes D, Curtis J, Freeman J. Long-Term Outcomes Following Left Atrial Appendage Occlusion in Medicare Beneficiaries: Outcomes From the National Cardiovascular Data Registry. Journal Of The American Heart Association 2025, 14: e039780. PMID: 40767285, DOI: 10.1161/jaha.124.039780.Peer-Reviewed Original ResearchConceptsNational Cardiovascular Data Registry LAAO RegistryCumulative incidence of ischemic strokeMedicare fee-for-service claims dataNational Cardiovascular Data RegistryCumulative incidenceIncidence of ischemic strokeCohort of Medicare patientsAll-Cause MortalityIschemic strokeFollow-upRetrospective cohort studyMedicare beneficiariesPatient valuesMedicare patientsClaims dataCumulative incidence of deathData registryCohort studyProbabilistic matchingPrimary outcomeMortality estimatesElderly populationAppendage occlusionOutcome dataPercutaneous left atrial appendage occlusionComparing Claims Data to Stroke and Bleeding in the NCDR Left Atrial Appendage Occlusion Registry
Faridi K, Freeman J, Wang Y, Pereira L, Zimmerman S, Friedman D, Sharma R, Higgins A, Mortazavi B, Ross J, Krumholz H, Yeh R, Curtis J. Comparing Claims Data to Stroke and Bleeding in the NCDR Left Atrial Appendage Occlusion Registry. JACC Advances 2025, 4: 102019. PMID: 40712270, PMCID: PMC12311505, DOI: 10.1016/j.jacadv.2025.102019.Peer-Reviewed Original ResearchInternational ClassificationPositive predictive valueClaims dataRegistry dataIncidence rateNational Cardiovascular Data Registry LAAO RegistryGastrointestinal bleedingIntracranial hemorrhageHemorrhagic strokeBleeding eventsIschemic strokePostmarketing surveillanceTranscatheter left atrial appendage occlusionInpatient hospitalizationSurveillance of therapyRevision codesMajor bleeding eventsNegative predictive valueKappa statisticRegistryRegistry patientsModerate agreementEstimates of sensitivityMajor bleedingAppendage occlusionHypertension Prevalence, Awareness, and Control in US Adults Before and After the COVID‐19 Pandemic
Essa M, Malik D, Lu Y, Yang H, Spatz E, Krumholz H, Faridi K. Hypertension Prevalence, Awareness, and Control in US Adults Before and After the COVID‐19 Pandemic. Journal Of Clinical Hypertension 2025, 27: e70093. PMID: 40685707, PMCID: PMC12277530, DOI: 10.1111/jch.70093.Peer-Reviewed Original ResearchConceptsHypertension prevalencePrevalence ratiosUS adultsAge-standardized prevalence estimatesAggressive public health effortsPublic health effortsPre-pandemicControl of hypertensionCOVID-19 pandemicHypertension awarenessHealth effortsPoisson regressionImpact of hypertensionPost-pandemicPrevalence estimatesNHANES dataNationwide prevalenceCause of deathUnited StatesBlood pressure controlNational trendsPrevalenceCOVID-19AdultsHypertensionPrioritizing Health - Dietary Approaches for Elevated LDL-C
Fishman ES, Ambrosini AP, Waring A, Faridi KF. Prioritizing Health - Dietary Approaches for Elevated LDL-C. American College of Cardiology Magazine. July 1, 2025. https://www.acc.org/Latest-in-Cardiology/Articles/2025/07/01/01/Prioritizing-Health-Dietary-Approaches-For-Elevated-LDL-CCommentaries, Editorials and LettersLipid-Lowering Therapy in the U.S. Adults Before and After the COVID-19 Pandemic
Essa M, Malik D, Lu Y, Yang H, Spatz E, Krumholz H, Faridi K. Lipid-Lowering Therapy in the U.S. Adults Before and After the COVID-19 Pandemic. JACC Advances 2025, 4: 101872. PMID: 40513221, PMCID: PMC12205634, DOI: 10.1016/j.jacadv.2025.101872.Peer-Reviewed Original ResearchInpatient Outcomes for Patients With Peripheral Artery Disease Hospitalized for Acute Myocardial Infarction
Gusdorf J, Faridi K, Wang T, Mena-Hurtado C, Smolderen K, Rymer J, Curtis J, Li S, Secemsky E. Inpatient Outcomes for Patients With Peripheral Artery Disease Hospitalized for Acute Myocardial Infarction. Journal Of The American Heart Association 2025, 14: e040526. PMID: 40497502, PMCID: PMC12229116, DOI: 10.1161/jaha.124.040526.Peer-Reviewed Original ResearchConceptsAcute myocardial infarction typesPeripheral arterial diseaseAcute myocardial infarctionIn-Hospital MortalityPeripheral artery disease hospitalizationsIn-Hospital OutcomesAcute myocardial infarction hospitalizationsCardiac arrestHigh-risk populationAssociated with increased ratesLong-term riskRevascularized PatientsInpatient outcomesMultivariable adjustmentHeart failureArtery diseasePrimary outcomeAdverse cardiovascular outcomesUS sitesHeightened riskAge groupsSecondary end pointsSubgroup analysisDialysis initiationCoronary artery diseaseTrends and Key Factors Associated With Racial and Ethnic Differences in Life’s Essential 8 Scores
Yang H, Huang C, Sawano M, Herrin J, Faridi K, Li Z, Spatz E, Krumholz H, Lu Y. Trends and Key Factors Associated With Racial and Ethnic Differences in Life’s Essential 8 Scores. JAMA Network Open 2025, 8: e2516663. PMID: 40531529, PMCID: PMC12177675, DOI: 10.1001/jamanetworkopen.2025.16663.Peer-Reviewed Original ResearchConceptsLife's Essential 8 scoreLife's Essential 8Cross-sectional studyWhite differencesEthnic differencesNational Health and Nutrition Examination SurveyHealth and Nutrition Examination SurveySleep health scoreNutrition Examination SurveyGroup-specific interventionsPrimary positive factorPhysical activityExamination SurveyHealth scoresBlack adultsWhite adultsMain OutcomesAsian adultsOverall scoreEvaluate trendsNicotine exposureEssential 8Blood lipidsAdultsEthnic groups10-Year and 30-Year Risks of Cardiovascular Disease in the U.S. Population
Faridi K, Malik D, Essa M, Yang H, Spatz E, Krumholz H, Lu Y. 10-Year and 30-Year Risks of Cardiovascular Disease in the U.S. Population. Journal Of The American College Of Cardiology 2025, 85: 2239-2249. PMID: 40499978, DOI: 10.1016/j.jacc.2025.03.546.Peer-Reviewed Original ResearchConceptsRisk of cardiovascular diseaseAtherosclerotic CVDU.S. adultsU.S. populationHispanic adultsCardiovascular diseaseCVD riskLong-term riskNational Health and Nutrition Examination SurveyHealth and Nutrition Examination SurveyRisk of atherosclerotic CVDElevated 10-year riskLong-term risk of cardiovascular diseaseAdults aged >Nutrition Examination SurveyTotal cardiovascular diseaseRisk factor profileRisk of total cardiovascular diseaseSurvey-weighted prevalenceMiddle-aged adultsPrevent Cardiovascular DiseaseHeart failureExamination SurveyAge-standardizedBlack adultsDays Alive Out of Hospital for Patients with Left Ventricular Dysfunction From the STICH Trial
Faridi K, Huang H, Parise H, Ahmad T, Mori M, Chung M, Yeh R, Petrie M, Panza J, Rouleau J, Dabrowski R, Velazquez E. Days Alive Out of Hospital for Patients with Left Ventricular Dysfunction From the STICH Trial. JACC Heart Failure 2025, 13: 867-869. PMID: 40335237, DOI: 10.1016/j.jchf.2025.02.019.Peer-Reviewed Original ResearchCoronary artery bypass surgery improves restricted mean survival time in patients with ischemic cardiomyopathy
Reinhardt S, Huang H, Parise H, Ahmad T, Velazquez E, Faridi K. Coronary artery bypass surgery improves restricted mean survival time in patients with ischemic cardiomyopathy. American Heart Journal Plus Cardiology Research And Practice 2025, 54: 100538. PMID: 40485767, PMCID: PMC12142554, DOI: 10.1016/j.ahjo.2025.100538.Peer-Reviewed Original ResearchCoronary Artery Bypass GraftingAll-Cause MortalityIschemic cardiomyopathyMean survival timeMedical therapyRestricted mean survival timeClinical trialsEndpoint of all-cause mortalityInternational multicenter randomized clinical trialSurvival timeCoronary artery bypass surgeryOptimal medical therapyMulticenter Randomized Clinical TrialBenefit of coronary artery bypass graftingEffect of coronary artery bypass graftingIschemic heart failureArtery bypass surgeryCox proportional hazards modelsArtery Bypass GraftingRandomized clinical trialsProportional hazards modelSurgical treatmentBypass surgeryHeart failureBypass Grafting
Clinical Trials
Current Trials
Multimodal Outcome CHAracterization (MOCHA) in comatose cardiac arrest patients
HIC ID1506016080REGRoleSub InvestigatorPrimary Completion Date12/31/2025Recruiting ParticipantsGenderBothAge18+ years
Academic Achievements & Community Involvement
Clinical Care
Overview
Kamil Faridi, MD, provides care for patients with complex cardiovascular medical conditions. He specializes in diagnosing and treating various arrhythmias.
Dr. Faridi's research interests include aortic stenosis detection and management, trends in cardiovascular medication use, and atrial fibrillation-related mortality. He also examines the challenges in evaluating specific heart valve issues and the impact of imaging techniques on procedures that prevent blood clots in the heart.
A Yale Center for Clinical Investigation (YCCI) Scholar and recipient of the K23 Career Development Award, Dr. Faridi's research has received support from the National Heart, Lung, and Blood Institute.
Dr. Faridi is an assistant professor at Yale University School of Medicine
Clinical Specialties
Cardiovascular Medicine
Board Certifications
Cardiovascular Disease
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2019
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2016
News
News
- November 05, 2024
Yale Researchers at American Heart Association Scientific Session 2024
- April 01, 2024
Yale Faculty Present Groundbreaking Clinical Research at the 2024 American College of Cardiology Scientific Sessions
- August 23, 2023
Artificial Intelligence Automates Diagnosis of Severe Heart Valve Disease
- August 07, 2023
Greater Use of Combination Therapy Would Reduce Heart Attacks and Strokes in Patients with Atherosclerotic Cardiovascular Disease, Yale Cardiologists Say